Owns the strategy, governance, and evolution of field intelligence capabilities, including analytics requirements, measurement frameworks, and capability roadmaps.
Consolidates and prioritizes field-related analytics and decision-support requirements across Insights & Analytics, partnering with strategy, platforms, and technology teams.
Serves as the primary coordination point for field intelligence and CRM analytics, operating in a globally integrated capability model.
Lead strategic planning, portfolio governance, and organizational performance management for the Decision Intelligence & Analytics Capabilities organization.
Act as the primary integrator driving cross-functional coordination, roadmap integration, and execution management across capability areas.
Ensure alignment of priorities, investments, resources, and strategic initiatives through a coordinated operating model.
Novartis is a global healthcare company focused on improving the lives of people living with disease through innovative science. The company operates with a collaborative culture and a large enterprise team committed to meeting the needs of patients and communities.
Lead enterprise-wide patient intelligence strategy, governance, and measurement frameworks.
Partner with analytics, data, and technology teams to align scalable solutions with business priorities.
Drive adoption of common definitions, methodologies, and KPIs across therapeutic areas.
This partner company operates in the healthcare sector, leveraging patient intelligence to drive strategic decisions. The culture is remote-first, collaborative, and inclusive, with a focus on enterprise-wide analytics and governance.
Build and maintain territory-level performance dashboards and scorecards for the US field organization.
Develop sub-national analyses including geographic demand modeling, ATC penetration analytics, and field force effectiveness.
Partner with commercial data systems to ensure data quality and deliver actionable insights to field leadership.
Iovance Biotherapeutics develops tumor infiltrating lymphocyte (TIL) cell therapies for solid tumors, including the FDA-approved Amtagvi for advanced melanoma. They are an end-to-end cell therapy company with centralized U.S. manufacturing and a growing commercial network.
Build and lead commercial data, advanced analytics, and forecasting capabilities to support launch readiness.
Develop patient-based forecasts and decision-support models to guide commercial strategy.
Translate complex data into actionable insights and KPIs for senior executives and operating teams.
REGENXBIO is a gene therapy company advancing a pipeline of treatments for rare and retinal diseases. The culture is purpose-driven and collaborative, with a focus on making a meaningful difference for patients and their families.
Own the Field Excellence operating model nationally, including cadence, standards, tools, and escalation protocols.
Serve as the single operational partner to the VP Sales, managing territory, IC questions, and business review preparation.
Manage and develop two Directors of Field Excellence and ensure launch readiness across all geographies.
Summit Therapeutics is a biopharmaceutical oncology company focused on improving quality of life and resolving serious unmet medical needs through clinical studies. The company is building its commercial infrastructure for a first US launch, with a mission-driven culture emphasizing integrity, collaboration, and commitment to people.
Lead commercial operations and analytics for the U.S. launch of deramiocel, a cell therapy for Duchenne muscular dystrophy.
Build and oversee commercial data ecosystem, analytics, forecasting, and field operations.
Establish scalable processes, governance, and cross-functional partnerships to drive launch readiness.
Capricor Therapeutics is a biotechnology company dedicated to advancing transformative cell and exosome-based therapies for rare diseases. The company is publicly traded and fosters a collaborative, mission-driven culture focused on innovation and patient impact.